Soft Tissue Ablation Made More Predictable
By HospiMedica International staff writers Posted on 28 Jul 2014 |
Image: Emprint ablation system antenna inserted into a tumor directly through the skin (Photo courtesy of Covidien).
An advanced ablation system offers physicians predictable results regardless of target location or tissue type.
The Emprint Ablation System with Thermosphere Technology is designed to precisely heat and destroy diseased soft tissue, including nonresectable tumors in the liver, lung, and kidney. The system provides clinicians three kinds of spatial energy control (thermal, field, and wavelength) to create spherical ablation zones regardless of target location, tissue type, or changes in tissue properties during a procedure. The system can be used in different procedure settings, including nonsurgical procedures directly through the skin, minimally invasive surgery (MIS), and open surgery.
The system included a 100 W ablation generator with an intuitive user interface and customizable power settings; an internally cooled percutaneous antenna with single body fiberglass construction (available in short, standard, and long lengths); an ablation pump for efficient antenna cooling to minimize thermal conductivity; and a remote temperature probe to verify tissue temperature in real time and trigger automatic ablation shut off when a preset tissue temperature is achieved. The Emprint Ablation System is a product of Covidien (Dublin, Ireland), and has been approved by the US Food and Drug Administration (FDA).
“Covidien is dedicated to improving patient safety and simplifying procedural options, and this innovative technology enables physicians to deliver precise ablation directly to soft tissue, including liver tumors,” said Chuck Brynelsen, president of early technologies at Covidien. “By providing predictable spherical ablation zones, this technology gives physicians more choices in terms of approach, further simplifying needle placement and saving planning and procedure time.”
Related Links:
Covidien
The Emprint Ablation System with Thermosphere Technology is designed to precisely heat and destroy diseased soft tissue, including nonresectable tumors in the liver, lung, and kidney. The system provides clinicians three kinds of spatial energy control (thermal, field, and wavelength) to create spherical ablation zones regardless of target location, tissue type, or changes in tissue properties during a procedure. The system can be used in different procedure settings, including nonsurgical procedures directly through the skin, minimally invasive surgery (MIS), and open surgery.
The system included a 100 W ablation generator with an intuitive user interface and customizable power settings; an internally cooled percutaneous antenna with single body fiberglass construction (available in short, standard, and long lengths); an ablation pump for efficient antenna cooling to minimize thermal conductivity; and a remote temperature probe to verify tissue temperature in real time and trigger automatic ablation shut off when a preset tissue temperature is achieved. The Emprint Ablation System is a product of Covidien (Dublin, Ireland), and has been approved by the US Food and Drug Administration (FDA).
“Covidien is dedicated to improving patient safety and simplifying procedural options, and this innovative technology enables physicians to deliver precise ablation directly to soft tissue, including liver tumors,” said Chuck Brynelsen, president of early technologies at Covidien. “By providing predictable spherical ablation zones, this technology gives physicians more choices in terms of approach, further simplifying needle placement and saving planning and procedure time.”
Related Links:
Covidien
Latest Surgical Techniques News
- Porous Gel Sponge Facilitates Rapid Hemostasis and Wound Healing
- Novel Rigid Endoscope System Enables Deep Tissue Imaging During Surgery
- Robotic Nerve ‘Cuffs’ Could Treat Various Neurological Conditions
- Flexible Microdisplay Visualizes Brain Activity in Real-Time To Guide Neurosurgeons
- Next-Gen Computer Assisted Vacuum Thrombectomy Technology Rapidly Removes Blood Clots
- Hydrogel-Based Miniaturized Electric Generators to Power Biomedical Devices
- Custom 3D-Printed Orthopedic Implants Transform Joint Replacement Surgery
- Wearable Technology Monitors and Analyzes Surgeons' Posture during Long Surgical Procedures
- Cutting-Edge Imaging Platform Detects Residual Breast Cancer Missed During Lumpectomy Surgery
- Computational Models Predict Heart Valve Leakage in Children
- Breakthrough Device Enables Clear and Real-Time Visual Guidance for Effective Cardiovascular Interventions
- World’s First Microscopic Probe to Revolutionize Early Cancer Diagnosis
- World’s Smallest Implantable Brain Stimulator Demonstrated in Human Patient
- Robotically Assisted Lung Transplants Could Soon Become a Reality
- AI to Provide Heart Transplant Surgeons with New Decision-Making Data
- New Surgical Tool Empowers Precision and Confidence in Operating Room